Phoska Biopharma Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

Phoska Biopharma General Information

Description

Operator of an artificial intelligence-based platform company based in Singapore. The company's biotech platform is used for multiple orphan diseases as well as in large neurodegenerative conditions, enabling healthcare companies to develop novel treatments for neurological diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 79 Science Park Drive
  • Number 06-01 Cintech IV
  • Singapore, 118264
  • Singapore
Primary Industry
Biotechnology
Corporate Office
  • 79 Science Park Drive
  • Number 06-01 Cintech IV
  • Singapore, 118264
  • Singapore

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Phoska Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private Completed Startup
2. Seed Round 31-Mar-2023 Completed Startup
1. Seed Round 18-Jul-2020 $1.35M $1.35M Completed Startup
To view Phoska Biopharma’s complete valuation and funding history, request access »

Phoska Biopharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Phoska Biopharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Phoska Biopharma Patents

Phoska Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022263927-A2 Plasmalogen derivatives and uses thereof Inactive 17-Jun-2021
WO-2022263927-A3 Plasmalogen derivatives and uses thereof Inactive 17-Jun-2021

Phoska Biopharma Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Albrekca Corporation Minority
Angel (individual) Minority
SPRIM Global Investments Holding Company Minority
To view Phoska Biopharma’s complete investors history, request access »

Phoska Biopharma Investments (1)

Phoska Biopharma’s most recent deal was a Corporate Asset Purchase with Op2Lysis (Certain Assets). The deal was made on 10-Apr-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Op2Lysis (Certain Assets) 10-Apr-2026 Corporate Asset Purchase Buildings and Property
To view Phoska Biopharma’s complete investments history, request access »

Phoska Biopharma FAQs

  • When was Phoska Biopharma founded?

    Phoska Biopharma was founded in 2019.

  • Where is Phoska Biopharma headquartered?

    Phoska Biopharma is headquartered in Singapore, Singapore.

  • What industry is Phoska Biopharma in?

    Phoska Biopharma’s primary industry is Biotechnology.

  • Is Phoska Biopharma a private or public company?

    Phoska Biopharma is a Private company.

  • What is Phoska Biopharma’s current revenue?

    The current revenue for Phoska Biopharma is .

  • How much funding has Phoska Biopharma raised over time?

    Phoska Biopharma has raised $3.55M.

  • Who are Phoska Biopharma’s investors?

    Albrekca, , and SPRIM Global Investments have invested in Phoska Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process